Lens implants vs. laser: which fix for nearsightedness comes out on top?

NCT ID NCT06700460

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This trial compares two ways to correct nearsightedness: implanting a small lens inside the eye (EVO+ ICL) and reshaping the cornea with a laser (LASIK). Researchers are measuring how well each procedure improves vision, as well as side effects like glare, dry eye, and night vision problems. The study includes 54 adults who are candidates for both procedures and will be randomly assigned to receive one or the other.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
two vision correction procedures: an implantable lens (EVO+ ICL) and laser eye surgery (LASIK)
What this could lead to
If this trial shows that ICL lenses are as good as or better than LASIK, it could offer people with nearsightedness a safe, effective alternative to laser surgery.
What could go wrong
This is a small, early-stage study with only 54 participants, so results may not apply to everyone. Both procedures carry risks like infection, dry eye, or visual disturbances.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Carolina Eyecare Physicians

    Mt. Pleasant, South Carolina, 29464, United States

  • Cleveland Eye Clinic

    Cleveland, Ohio, 44035, United States

  • Kugler Vision

    Omaha, Nebraska, 68118, United States

  • Slade & Baker Vision

    Houston, Texas, 77027, United States

  • Vance Thompson Vision Clinic

    Sioux Falls, South Dakota, 57108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.